We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
OSUR

Price
3.00
Stock movement down
-0.04 (-1.38%)
Company name
OraSure Technologies Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Markedsværdi
209.17M
Ent værdi
-30.88M
Pris/omsætning
1.13
Pris/bog
0.49
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
0.02%
Efterfølgende P/E
18.40
Fremtidig P/E
-
PEG
-
EPS-vekst
17.20%
1 års afkast
-33.02%
3 års afkast
-13.38%
5 års afkast
-26.33%
10 års afkast
-6.28%
Senest opdateret: 2025-09-15

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UDBYTTE

OSUR betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E18.40
Pris til OCF3.05
Pris til FCF3.27
Pris til EBITDA18.18
EV i forhold til EBITDA-2.68

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning1.13
Pris til egenkapital0.49
EV i forhold til salg-0.17

iO Charts is a Seeking Alpha partner

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier73.14M
EPS (TTM)0.15
FCF pr. aktie (TTM)0.86

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)184.61M
Bruttofortjeneste (TTM)102.59M
Driftsindkomst (TTM)-1.64M
Nettoindkomst (TTM)11.37M
EPS (TTM)0.15
EPS (1 år frem)-0.40

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)55.57%
Driftsmargin (TTM)-0.89%
Fortjenstmargin (TTM)6.16%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter278.57M
Nettotilgodehavender26.95M
Omsætningsaktiver i alt350.15M
Goodwill35.29M
Immaterielle aktiver665.00K
Ejendomme, anlæg og udstyr127.77M
Sum aktiver464.08M
Kreditor9.58M
Kortfristet/nuværende langsigtet gæld11.11M
Summen af kortfristede forpligtelser27.78M
Sum gæld38.52M
Aktionærernes egenkapital425.56M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)68.63M
Investeringsudgifter (TTM)4.63M
Fri pengestrøm (TTM)64.00M
Udbetalt udbytte (TTM)10.00K

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast2.67%
Afkast af aktiver2.45%
Afkast af investeret kapital2.65%
Kontant afkast af investeret kapital14.94%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning2.87
Daglig høj2.92
Daglig lav2.85
Daglig volumen254K
Højeste gennem alle tider27.00
1 års analytiker estimat6.00
Beta0.27
EPS (TTM)0.15
Udbytte pr. aktie-
Ex-div dato8 Jan 1998
Næste dato for resultatpræsentation5 Nov 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
OSURS&P500
Nuværende prisfald fra top notering-89.41%-1.46%
Højeste prisfald-91.67%-56.47%
Højeste efterår dato9 Mar 20099 Mar 2009
Gennemsnitlig fald fra toppen-62.32%-10.99%
Gennemsnitlig tid til nyt højdepunkt264 days12 days
Maks. tid til nyt højdepunkt8460 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

OPLYSNINGER OM VIRKSOMHEDEN
OSUR (OraSure Technologies Inc) company logo
Markedsværdi
209.17M
Markedsværdi kategori
Small-cap
Beskrivelse
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally. The company's products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, and OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; and Colli-Pee collection devices for the volumetric collection of void urine samples. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, the company develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is h
Personale
501
Investor relationer
-
SEC-indsendelser
Adm. direktør
Stephen S. Tang
Land
USA
By
Bethlehem
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FORSTÅ FORRETNINGEN
Loading...